Irene Seipelt

USPTO Granted Patents = 13 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 7)

Average Co-Inventor Count = 6.0

ph-index = 2

Forward Citations = 16(Granted Patents)

Company Filing History:

11 out of 36

Aeterna Zentaris Gmbh

Years Active: 2007-2015

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8937068 - Pyridopyrazine derivatives and their use (2015-01-20),

2. 8912189 - Pyridopyrazine derivatives and their use (2014-12-16),

3. 8791118 - Pyridopyrazines as highly selective ras-Raf-Mek-Erk signal transduction pathway inhibitors (2014-07-29),

4. 8604196 - Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1H-pyrazol-4-yl)-pyrido[2.3-B]pyrazine-6-yl]thiourea (2013-12-10),

5. 8536332 - Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines (2013-09-17),

6. 8507486 - Pyridopyrazine derivatives, process of manufacturing and uses thereof (2013-08-13),

7. 8461178 - Naphthyridine derivatives and the use thereof as kinase inhibitors (2013-06-11),

8. 8394801 - Quinoxaline derivatives and their use for treating benign and malignant tumour disorders (2013-03-12),

9. 8217042 - Pyridopyrazines and their use as modulators of kinases (2012-07-10),

10. 8202883 - Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases (2012-06-19),

11. 8193186 - Pyridopyrazines and the use thereof as kinase inhibitors (2012-06-05),

12. 7323468 - Pyridopyrazines and the use thereof as kinase inhibitors (2008-01-29),

13. 7276507 - Pyridopyrazines and the use thereof as kinase inhibitors (2007-10-02),

Title: Irene Seipelt: Innovator in Pyridopyrazine Compounds

Introduction

Irene Seipelt is a prominent inventor based in Offenbach, Germany. She has made significant contributions to the field of medicinal chemistry, particularly through her work on pyridopyrazine derivatives. With a total of 13 patents to her name, Seipelt has established herself as a key figure in the development of compounds aimed at treating various physiological and pathophysiological conditions.

Latest Patents

Her latest patents focus on pyridopyrazine compounds that are suitable for the treatment or prevention of physiological and/or pathophysiological states mediated and/or modulated by signal transduction pathways and/or enzymes in mammals, particularly in humans. These innovative compounds are described in detail in her patents, which outline their potential applications in medical treatments.

Career Highlights

Throughout her career, Irene Seipelt has worked with notable companies such as Aeterna Zentaris GmbH and Zentaris GmbH. Her work in these organizations has allowed her to advance her research and contribute to the development of new therapeutic agents.

Collaborations

Irene has collaborated with esteemed colleagues, including Eckhard Claus and Eckhard Guenther, to further her research and enhance the impact of her inventions.

Conclusion

Irene Seipelt's innovative work in the field of pyridopyrazine compounds showcases her dedication to advancing medical science. Her contributions have the potential to significantly impact the treatment of various health conditions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

2 patents pending:

Please report any incorrect information to support@idiyas.com

3 patents (EPO):

Please report any incorrect information to support@idiyas.com

7 patents pending (EPO):

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.